Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXHL2500114	AMG 890	olpasiran	Active ingredient	Chemical Drugs(1)	Import Drug Application	2025-05-17		Amgen Inc;Amgen Biology Technology Consulting (Shanghai) Co Ltd			view
JXHL2500115	AMG 890	olpasiran	Active ingredient	Chemical Drugs(1)	Import Drug Application	2025-05-17		Amgen Inc;Amgen Biology Technology Consulting (Shanghai) Co Ltd			view
JXHB2500050	AMG 890	olpasiran	Active ingredient	Chemical Drugs(1)	Supplementary Application	2025-04-19		Amgen Inc			view
JXHB2500028	AMG 890	olpasiran	Active ingredient	Chemical Drugs(1)	Supplementary Application	2025-03-28		Amgen Inc			view
JXHL2300100	AMG 890	olpasiran	Active ingredient	Chemical Drugs(1)	Import Drug Application	2023-04-29		Amgen Inc;Amgen Biology Technology Consulting (Shanghai) Co Ltd			view
JXHL2300001	AMG 890	olpasiran	Active ingredient	Chemical Drugs(1)	Import Drug Application	2023-01-07		Amgen Inc;Amgen Biology Technology Consulting (Shanghai) Co Ltd			view
JXHL2000295	AMG 890	olpasiran	Active ingredient	Chemical Drugs(1)	Import Drug Application	2020-11-07	安进生物技术咨询（上海）有限公司	Amgen Biology Technology Consulting (Shanghai) Co Ltd;Amgen Inc	In Review	2020-11-06	view